-
1دورية أكاديمية
المؤلفون: Wang, C., Barnoud, C., Cenerenti, M., Sun, M., Caffa, I., Kizil, B., Bill, R., Liu, Y., Pick, R., Garnier, L., Gkountidi, O.A., Ince, L.M., Holtkamp, S., Fournier, N., Michielin, O., Speiser, D.E., Hugues, S., Nencioni, A., Pittet, M.J., Jandus, C., Scheiermann, C.
المصدر: Nature, vol. 614, no. 7946, pp. 136-143
مصطلحات موضوعية: Animals, Humans, Mice, CD8-Positive T-Lymphocytes/immunology, Dendritic Cells/immunology, Immunotherapy/methods, Melanoma/immunology, Melanoma/pathology, Melanoma/therapy, Inbred C57BL, B7-1 Antigen, Antigens, Neoplasm/immunology, Lymph Nodes, Circadian Rhythm/immunology
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36470303; info:eu-repo/semantics/altIdentifier/eissn/1476-4687; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_33489F389D056; https://serval.unil.ch/notice/serval:BIB_33489F389D05Test; urn:issn:0028-0836; https://serval.unil.ch/resource/serval:BIB_33489F389D05.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_33489F389D056Test
الإتاحة: https://doi.org/10.1038/s41586-022-05605-0Test
https://serval.unil.ch/notice/serval:BIB_33489F389D05Test
https://serval.unil.ch/resource/serval:BIB_33489F389D05.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_33489F389D056Test -
2دورية أكاديمية
المؤلفون: Harris, Robert J, Willsmore, Zena, Laddach, Roman, Crescioli, Silvia, Chauhan, Jitesh, Cheung, Anthony, Black, Anna, Geh, Jenny L C, MacKenzie Ross, Alastair D, Healy, Ciaran, Tsoka, Sophia, Spicer, James, Lacy, Katie E., Karagiannis, Sophia N
المصدر: Harris , R J , Willsmore , Z , Laddach , R , Crescioli , S , Chauhan , J , Cheung , A , Black , A , Geh , J L C , MacKenzie Ross , A D , Healy , C , Tsoka , S , Spicer , J , Lacy , K E & Karagiannis , S N 2022 , ' Enriched circulating and tumor-resident TGF-β+ regulatory B cells in patients with melanoma promote FOXP3+ Tregs ' , OncoImmunology , vol. 11 , no. 1 , 2104426 , pp. 2104426 . https://doi.org/10.1080/2162402X.2022.2104426Test
مصطلحات موضوعية: B-Lymphocytes, Regulatory/immunology, Forkhead Transcription Factors/metabolism, Humans, Melanoma/immunology, Skin Neoplasms/immunology, T-Lymphocytes, Transforming Growth Factor beta/genetics, Tumor Microenvironment, Tumor Necrosis Factor-alpha/metabolism
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1080/2162402X.2022.2104426Test
https://kclpure.kcl.ac.uk/portal/en/publications/a3b9fc84-0abf-4957-9a48-152d0e87e5f3Test
https://kclpure.kcl.ac.uk/ws/files/177881826/Harris_et_al_Oncoimmunology_2022_2162402X.2022.pdfTest
http://www.scopus.com/inward/record.url?scp=85135179139&partnerID=8YFLogxKTest -
3دورية أكاديمية
المؤلفون: Purde, Mette-Triin, Niederer, Rebekka, Wagner, Nikolaus B., Diem, Stefan, Berner, Fiamma, Hasan Ali, Omar, Hillmann, Dorothea, Bergamin, Irina, Joerger, Markus, Risch, Martin, Niederhauser, Christoph, Lenz, Tobias L., Früh, Martin, Risch, Lorenz, Semela, David, Flatz, Lukas
المصدر: http://lobid.org/resources/99370674181806441Test#!, 148(3):647-656.
مصطلحات موضوعية: Switzerland/epidemiology [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Autoantibodies/immunology [MeSH], Drug-induced liver injury, Male [MeSH], Hepatitis/immunology [MeSH], Immune Checkpoint Inhibitors/adverse effects [MeSH], Melanoma/pathology [MeSH], Lung Neoplasms/immunology [MeSH], Case-Control Studies [MeSH], Drug-related side effects and adverse reactions, Autoantibodies, Melanoma/drug therapy [MeSH], Carcinoma, Non-Small-Cell Lung/pathology [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Checkpoint inhibitors, Original Article – Cancer Research, Adult [MeSH], Autoantibodies/blood [MeSH], Humans [MeSH], Prospective Studies [MeSH], Hepatitis/epidemiology [MeSH], Middle Aged [MeSH], Hepatitis/blood [MeSH], Survival Rate [MeSH], Melanoma/immunology [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6446876Test; https://doi.org/10.1007/s00432-021-03870-6Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881258Test/
الإتاحة: https://doi.org/10.1007/s00432-021-03870-6Test
https://repository.publisso.de/resource/frl:6446876Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881258Test/ -
4دورية أكاديمية
المؤلفون: Hassel, Jessica C.
المصدر: http://lobid.org/resources/99370671962606441Test#!, 126(2):163-164.
مصطلحات موضوعية: Humans [MeSH], Treatment Outcome [MeSH], Molecular Medicine, Drug Resistance, Oncology, Editorial, Epidemiology, Survival Rate [MeSH], Cancer Research, Immune Checkpoint Inhibitors/adverse effects [MeSH], Melanoma/immunology [MeSH], Melanoma/pathology [MeSH], Biomedicine, general, Autoimmunity [MeSH], Melanoma/drug therapy [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6442876Test; https://doi.org/10.1038/s41416-021-01390-1Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770793Test/
الإتاحة: https://doi.org/10.1038/s41416-021-01390-1Test
https://repository.publisso.de/resource/frl:6442876Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770793Test/ -
5دورية أكاديمية
المؤلفون: Ressler, J.M., Karasek, M., Koch, L., Silmbrod, R., Mangana, J., Latifyan, S., Aedo-Lopez, V., Kehrer, H., Weihsengruber, F., Koelblinger, P., Posch, C., Kofler, J., Michielin, O., Richtig, E., Hafner, C., Hoeller, C.
المصدر: Journal for immunotherapy of cancer, vol. 9, no. 2, pp. e001701
مصطلحات موضوعية: Adult, Aged, 80 and over, Biological Products/adverse effects, Biological Products/therapeutic use, Disease Progression, Europe, Female, Herpesvirus 1, Human/immunology, Human/pathogenicity, Humans, Male, Melanoma/immunology, Melanoma/pathology, Melanoma/therapy, Middle Aged, Neoplasm Staging, Oncolytic Viruses/immunology, Oncolytic Viruses/pathogenicity, Retrospective Studies, Skin Neoplasms/immunology, Skin Neoplasms/pathology, Skin Neoplasms/therapy, Skin Neoplasms/virology, Time Factors, Treatment Outcome, immunotherapy, melanoma, oncolytic virotherapy
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33608376; info:eu-repo/semantics/altIdentifier/eissn/2051-1426; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_044C379CA9CC7; https://serval.unil.ch/notice/serval:BIB_044C379CA9CCTest; urn:issn:2051-1426; https://serval.unil.ch/resource/serval:BIB_044C379CA9CC.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_044C379CA9CC7Test
الإتاحة: https://doi.org/10.1136/jitc-2020-001701Test
https://serval.unil.ch/notice/serval:BIB_044C379CA9CCTest
https://serval.unil.ch/resource/serval:BIB_044C379CA9CC.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_044C379CA9CC7Test -
6دورية أكاديمية
المؤلفون: Dillard, Pierre, Köksal, Hakan, Maggadóttir, Sólrún Melkorka, Winge-Main, Anna, Pollmann, Sylvie, Menard, Mathilde, Myhre, Marit Renée, Mælandsmo, Gunhild M., Flørenes, Vivi Ann, Gaudernack, Gustav, Kvalheim, Gunnar, Wälchli, Sébastien, Inderberg, Else Marit
المساهمون: Faculty of Medicine
مصطلحات موضوعية: Meðferð, Krabbamein, T-frumur, CD4 T cell, immunotherapy, in vivo model, MHC class II, solid tumor, T cell receptor, telomerase, Cell Proliferation, Immunotherapy/methods, Humans, Histocompatibility Antigens Class II/immunology, Melanoma/immunology, Mice, SCID, Xenograft Model Antitumor Assays, CD8-Positive T-Lymphocytes/immunology, Telomerase/antagonists & inhibitors, Animals, Receptors, Antigen, T-Cell/immunology, Inbred NOD, Tumor Cells, Cultured, T-Lymphocytes, Cytotoxic/immunology, Apoptosis
وصف الملف: 1199-1213
العلاقة: Molecular Therapy; 29(3); http://www.scopus.com/inward/record.url?scp=85097471349&partnerID=8YFLogxKTest; Dillard , P , Köksal , H , Maggadóttir , S M , Winge-Main , A , Pollmann , S , Menard , M , Myhre , M R , Mælandsmo , G M , Flørenes , V A , Gaudernack , G , Kvalheim , G , Wälchli , S & Inderberg , E M 2021 , ' Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy ' , Molecular Therapy , vol. 29 , no. 3 , pp. 1199-1213 . https://doi.org/10.1016/j.ymthe.2020.11.019Test; 86a97021-3b5b-4084-b873-92712a36b739; 85097471349; https://hdl.handle.net/20.500.11815/2893Test
الإتاحة: https://doi.org/20.500.11815/2893Test
https://doi.org/10.1016/j.ymthe.2020.11.019Test
https://hdl.handle.net/20.500.11815/2893Test -
7دورية أكاديميةBRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
المؤلفون: Peiffer, Lukas, Farahpour, Farnoush, Sriram, Ashwin, Spassova, Ivelina, Hoffmann, Daniel, Kubat, Linda, Stoitzner, Patrizia, Gambichler, Thilo, Sucker, Antje, Ugurel, Selma, Schadendorf, Dirk, Becker, Jürgen
المصدر: http://lobid.org/resources/99370671253406441Test#!, 70(6):1635-1647.
مصطلحات موضوعية: Gene Expression Regulation, Neoplastic [MeSH], Melanoma/metabolism [MeSH], T-cell receptor repertoire, Lymphocytes, Tumor-Infiltrating/drug effects [MeSH], Tumor microenvironment, Original Article, Tumor Cells, Cultured [MeSH], Melanoma/pathology [MeSH], Biomarkers, Tumor/analysis [MeSH], Melanoma/drug therapy [MeSH], CTA, Cellular Reprogramming [MeSH], Proto-Oncogene Proteins B-raf/antagonists, TCF7, MDA, Receptors, Antigen, T-Cell/metabolism [MeSH], Humans [MeSH], T Cell Transcription Factor 1/metabolism [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Tumor-Infiltrating/immunology [MeSH], T Cell Transcription Factor 1/genetics [MeSH], MAP Kinase Kinase 1/antagonists, Melanoma/immunology [MeSH], Prognosis [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6470082Test; https://doi.org/10.1007/s00262-020-02804-4Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139931Test/
الإتاحة: https://doi.org/10.1007/s00262-020-02804-4Test
https://repository.publisso.de/resource/frl:6470082Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139931Test/ -
8دورية أكاديمية
المؤلفون: Watanabe, Tsubasa, Firat, Elke, Scholber, Jutta, Gaedicke, Simone, Heinrich, Corinne, Luo, Ren, Ehrat, Nicolas, Multhoff, Gabriele, Schmitt-Graeff, Annette, Grosu, Anca-Ligia, Abdollahi, Amir, Hassel, Jessica C., von Bubnoff, Dagmar, Meiss, Frank, Niedermann, Gabriele
المصدر: http://lobid.org/resources/99370671253406441Test#!, 69(9):1823-1832.
مصطلحات موضوعية: Melanoma/therapy [MeSH], Female [MeSH], Immune checkpoint blockade, Aged [MeSH], Abscopal effects, Humans [MeSH], Melanoma/radiotherapy [MeSH], Immune signatures, Radiosurgery/methods [MeSH], Original Article, Epitopes, T-Lymphocyte/immunology [MeSH], Immunotherapy/methods [MeSH], Male [MeSH], Melanoma/immunology [MeSH], Programmed Cell Death 1 Receptor/immunology [MeSH], Hypofractionated radiotherapy, CD8-Positive T-Lymphocytes/immunology [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6470060Test; https://doi.org/10.1007/s00262-020-02587-8Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413872Test/
الإتاحة: https://doi.org/10.1007/s00262-020-02587-8Test
https://repository.publisso.de/resource/frl:6470060Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413872Test/ -
9دورية أكاديمية
المؤلفون: Puig-Saus, C., Sennino, B., Peng, S., Wang, C.L., Pan, Z., Yuen, B., Purandare, B., An, D., Quach, B.B., Nguyen, D., Xia, H., Jilani, S., Shao, K., McHugh, C., Greer, J., Peabody, P., Nayak, S., Hoover, J., Said, S., Jacoby, K., Dalmas, O., Foy, S.P., Conroy, A., Yi, M.C., Shieh, C., Lu, W., Heeringa, K., Ma, Y., Chizari, S., Pilling, M.J., Ting, M., Tunuguntla, R., Sandoval, S., Moot, R., Hunter, T., Zhao, S., Saco, J.D., Perez-Garcilazo, I., Medina, E., Vega-Crespo, A., Baselga-Carretero, I., Abril-Rodriguez, G., Cherry, G., Wong, D.J., Hundal, J., Chmielowski, B., Speiser, D.E., Bethune, M.T., Bao, X.R., Gros, A., Griffith, O.L., Griffith, M., Heath, J.R., Franzusoff, A., Mandl, S.J., Ribas, A.
المصدر: Nature, vol. 615, no. 7953, pp. 697-704
مصطلحات موضوعية: Humans, Antigens, Neoplasm/immunology, CD8-Positive T-Lymphocytes/immunology, CD8-Positive T-Lymphocytes/metabolism, Immunotherapy, Melanoma/drug therapy, Melanoma/genetics, Melanoma/immunology, Melanoma/pathology, Receptors, Antigen, T-Cell/immunology, T-Cell/metabolism, Immune Checkpoint Inhibitors/pharmacology, Immune Checkpoint Inhibitors/therapeutic use, HLA Antigens/immunology, Neoplasm Metastasis, Precision Medicine, Gene Editing, CRISPR-Cas Systems, Mutation
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36890230; info:eu-repo/semantics/altIdentifier/eissn/1476-4687; https://serval.unil.ch/notice/serval:BIB_B490E5522790Test; urn:issn:0028-0836
الإتاحة: https://doi.org/10.1038/s41586-023-05787-1Test
https://serval.unil.ch/notice/serval:BIB_B490E5522790Test -
10دورية أكاديمية
المؤلفون: Siddiqui, I., Schaeuble, K., Chennupati, V., Fuertes Marraco, S.A., Calderon-Copete, S., Pais Ferreira, D., Carmona, S.J., Scarpellino, L., Gfeller, D., Pradervand, S., Luther, S.A., Speiser, D.E., Held, W.
المصدر: Immunity, vol. 50, no. 1, pp. 195-211.e10
مصطلحات موضوعية: Animals, Antibodies, Monoclonal/therapeutic use, CD8-Positive T-Lymphocytes/drug effects, CD8-Positive T-Lymphocytes/immunology, Cell Differentiation, Cell Proliferation, Hepatitis A Virus Cellular Receptor 2/antagonists & inhibitors, Hepatocyte Nuclear Factor 1-alpha/genetics, Hepatocyte Nuclear Factor 1-alpha/metabolism, Humans, Immunotherapy, Lymphocytes, Tumor-Infiltrating/drug effects, Tumor-Infiltrating/immunology, Melanoma/immunology, Melanoma/therapy, Melanoma, Experimental, Mice, Inbred C57BL, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Stem Cells/immunology, T-Lymphocyte Subsets/immunology, T cell exhaustion, T cell factor 1, T cell reinvigoration, cancer immunotherapy, checkpoint blockade, memory-like T cells
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30635237; info:eu-repo/semantics/altIdentifier/eissn/1097-4180; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_8DBCBF3E53B57; https://serval.unil.ch/notice/serval:BIB_8DBCBF3E53B5Test; urn:issn:1074-7613; https://serval.unil.ch/resource/serval:BIB_8DBCBF3E53B5.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_8DBCBF3E53B57Test
الإتاحة: https://doi.org/10.1016/j.immuni.2018.12.021Test
https://serval.unil.ch/notice/serval:BIB_8DBCBF3E53B5Test
https://serval.unil.ch/resource/serval:BIB_8DBCBF3E53B5.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_8DBCBF3E53B57Test